Matches in Nanopublications for { ?s ?p "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 20 of
20
with 100 items per page.
- NP326177.RAeroXdaTB_YMAKvmhtVxKg1kfBlNO7Mc2_Wm3zyuoQ9A130_assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326177.RAeroXdaTB_YMAKvmhtVxKg1kfBlNO7Mc2_Wm3zyuoQ9A130_provenance.
- NP355992.RAENB-Aeti-B6HzDAp9ZcdrI5Hxo7z9CcigmgjuOvIPo8130_assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP355992.RAENB-Aeti-B6HzDAp9ZcdrI5Hxo7z9CcigmgjuOvIPo8130_provenance.
- NP457374.RA38uezZgO3ggGiLsxI1S6vlfHDM_VZ2OkoENlwf-OeHI130_assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP457374.RA38uezZgO3ggGiLsxI1S6vlfHDM_VZ2OkoENlwf-OeHI130_provenance.
- NP750405.RA69H6vketxHBgghyrEAOjefeKmREngGWg76Is4a5AG04130_assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP750405.RA69H6vketxHBgghyrEAOjefeKmREngGWg76Is4a5AG04130_provenance.
- assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP979616.RAU4AX11CC8Rd8DAG6ucOFdHQaPvOOuPwTTx_Dg6pgLY8130_assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979616.RAU4AX11CC8Rd8DAG6ucOFdHQaPvOOuPwTTx_Dg6pgLY8130_provenance.
- NP979619.RAWIJEnQZKocRISj4gX5uAxG_ghIa9jsPlYPHJXIDr6qw130_assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979619.RAWIJEnQZKocRISj4gX5uAxG_ghIa9jsPlYPHJXIDr6qw130_provenance.
- NP979621.RAVzbqxqw7tGMWGGrFVXBDvy1qBnrJyxaRkicmbKVV9M4130_assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979621.RAVzbqxqw7tGMWGGrFVXBDvy1qBnrJyxaRkicmbKVV9M4130_provenance.
- NP979618.RAD363w0prgMd4xUq235ecS_iE9YzRI54nQhyi5hB-thY130_assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979618.RAD363w0prgMd4xUq235ecS_iE9YzRI54nQhyi5hB-thY130_provenance.
- NP979617.RAsRaLXREWk_Yr8rr3u_XwJxKx_BPhoc9nLSOSNzD4WiE130_assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979617.RAsRaLXREWk_Yr8rr3u_XwJxKx_BPhoc9nLSOSNzD4WiE130_provenance.
- NP979620.RAKkRPuB1cOfOwXMYdLXzVUO4EX6uEG63f6XmOo3xrvqY130_assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979620.RAKkRPuB1cOfOwXMYdLXzVUO4EX6uEG63f6XmOo3xrvqY130_provenance.
- NP979622.RA2g9vnqH-7h5VkTTWUrvuuiMfOBN5Unh9I-vK9H5LoB8130_assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979622.RA2g9vnqH-7h5VkTTWUrvuuiMfOBN5Unh9I-vK9H5LoB8130_provenance.
- NP979623.RAyE_Wkn4Y-GbNM3wRKTbtDCFUTAGVRUOrXhBT9dmz1Jo130_assertion description "[Evidence that the phosphoinositide 3-kinase (PI3K) pathway is deregulated in ovarian cancer is largely based on the analysis of surgical specimens sampled at diagnosis and may not reflect the biology of advanced ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979623.RAyE_Wkn4Y-GbNM3wRKTbtDCFUTAGVRUOrXhBT9dmz1Jo130_provenance.